title: Recommendations for prophylaxis of pregnancy-related venous thromboembolism in carriers of inherited thrombophilia. Comment on the 2012 ACCP guidelines: a rebuttal.
authors.affiliation: McMaster University, Hamilton, ON, Canada.
authors.forename: S M
authors.initials: SM
authors.lastname: Bates
authors.forename: I A
authors.initials: IA
authors.lastname: Greer
authors.forename: S
authors.initials: S
authors.lastname: Middeldorp
authors.forename: D L
authors.initials: DL
authors.lastname: Veenstra
authors.forename: A-M
authors.initials: AM
authors.lastname: Prabulos
authors.forename: P O
authors.initials: PO
authors.lastname: Vandvik
mesh_terms: D019317:Evidence-Based Medicine; D005260:Female; D005343:Fibrinolytic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy* / Q000517:prevention & control*; D012955:Societies, Medical; D019851:Thrombophilia / Q000188:drug therapy*; D054556:Venous Thromboembolism / Q000188:drug therapy* / Q000517:prevention & control*
chemical_list: D005343:Fibrinolytic Agents